Holdings (Monthly)
Guide ↗
Biotechnology Fund
· Rydex Series Funds| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | AbbVie Inc. | ABBV | Mar 2026 | 45,923 | $10.0M | 7.39% | EC |
| 2 | Amgen Inc. | AMGN | Mar 2026 | 20,093 | $7.1M | 5.23% | EC |
| 3 | Gilead Sciences Inc. | GILD | Mar 2026 | 48,042 | $6.7M | 4.96% | EC |
| 4 | Vertex Pharmaceuticals Incorporated | VRTX | Mar 2026 | 12,119 | $5.4M | 4.01% | EC |
| 5 | Regeneron Pharmaceuticals, Inc. | REGN | Mar 2026 | 6,224 | $4.8M | 3.56% | EC |
| 6 | Alnylam Pharmaceuticals Inc. | ALNY | Mar 2026 | 10,632 | $3.5M | 2.60% | EC |
| 7 | Insmed Inc | INSM | Mar 2026 | 20,277 | $3.3M | 2.45% | EC |
| 8 | BEONE MEDICINES LTD | ONC | Mar 2026 | 10,395 | $3.1M | 2.29% | EC |
| 9 | NATERA INC | NTRA | Mar 2026 | 14,145 | $2.8M | 2.09% | EC |
| 10 | United Therapeutics Corporation | UTHR | Mar 2026 | 4,711 | $2.8M | 2.07% | EC |
| 11 | Biogen Inc | BIIB | Mar 2026 | 14,803 | $2.7M | 2.01% | EC |
| 12 | Royalty Pharma PLC | RPRX | Mar 2026 | 55,739 | $2.7M | 1.98% | EC |
| 13 | Illumina Inc | ILMN | Mar 2026 | 19,053 | $2.3M | 1.74% | EC |
| 14 | Revolution Medicines Inc | RVMD | Mar 2026 | 23,475 | $2.3M | 1.69% | EC |
| 15 | Moderna Inc | MRNA | Mar 2026 | 43,818 | $2.2M | 1.65% | EC |
| 16 | AstraZeneca PLC | AZN | Mar 2026 | 10,974 | $2.2M | 1.60% | EC |
| 17 | Argenx SE | ARGX | Mar 2026 | 2,961 | $2.2M | 1.60% | EC |
| 18 | Incyte Corporation. | INCY | Mar 2026 | 22,317 | $2.1M | 1.56% | EC |
| 19 | Viatris Inc | VTRS | Mar 2026 | 150,073 | $2.0M | 1.50% | EC |
| 20 | Bridgebio Pharma Inc | BBIO | Mar 2026 | 26,764 | $2.0M | 1.47% | EC |
| 21 | Alkermes PLC | ALKS | Mar 2026 | 56,068 | $2.0M | 1.47% | EC |
| 22 | Jazz Pharmaceuticals PLC | JAZZ | Mar 2026 | 10,448 | $2.0M | 1.46% | EC |
| 23 | Neurocrine Biosciences Inc | NBIX | Mar 2026 | 14,527 | $1.9M | 1.42% | EC |
| 24 | Guardant Health Inc | GH | Mar 2026 | 20,606 | $1.9M | 1.41% | EC |
| 25 | Roivant Sciences Ltd | ROIV | Mar 2026 | 68,372 | $1.9M | 1.40% | EC |
| 26 | Ionis Pharmaceuticals, Inc. | IONS | Mar 2026 | 24,870 | $1.9M | 1.38% | EC |
| 27 | Exelixis, Inc. | EXEL | Mar 2026 | 40,607 | $1.7M | 1.29% | EC |
| 28 | Medpace Holdings Inc. | MEDP | Mar 2026 | 3,540 | $1.7M | 1.26% | EC |
| 29 | Biomarin Pharmaceutical Inc. | BMRN | Mar 2026 | 29,738 | $1.7M | 1.24% | EC |
| 30 | Apellis Pharmaceuticals Inc | APLS | Mar 2026 | 41,107 | $1.7M | 1.22% | EC |
| 31 | Arrowhead Pharmaceuticals Inc | ARWR | Mar 2026 | 26,370 | $1.7M | 1.22% | EC |
| 32 | Cytokinetics Inc | CYTK | Mar 2026 | 24,093 | $1.6M | 1.18% | EC |
| 33 | Vaxcyte Inc | PCVX | Mar 2026 | 26,383 | $1.5M | 1.14% | EC |
| 34 | CRISPR Therapeutics AG | CRSP | Mar 2026 | 32,054 | $1.5M | 1.13% | EC |
| 35 | Halozyme Therapeutics Inc | HALO | Mar 2026 | 22,712 | $1.5M | 1.09% | EC |
| 36 | BioNTech SE | BNTX | Mar 2026 | 16,159 | $1.4M | 1.06% | EC |
| 37 | Axsome Therapeutics Inc. | AXSM | Mar 2026 | 8,171 | $1.4M | 1.02% | EC |
| 38 | Ascendis Pharma A/S | ASND | Mar 2026 | 5,974 | $1.4M | 1.01% | EC |
| 39 | COGENT BIOSCIENCES INC | COGT | Mar 2026 | 34,752 | $1.3M | 0.99% | EC |
| 40 | Arcellx Inc | ACLX | Mar 2026 | 11,645 | $1.3M | 0.99% | EC |
| 41 | TG Therapeutics Inc | TGTX | Mar 2026 | 39,225 | $1.3M | 0.96% | EC |
| 42 | PTC Therapeutics, Inc. | PTCT | Mar 2026 | 18,935 | $1.3M | 0.96% | EC |
| 43 | Scholar Rock Holding Corp. | SRRK | Mar 2026 | 25,883 | $1.3M | 0.94% | EC |
| 44 | Madrigal Pharmaceuticals Inc | MDGL | Mar 2026 | 2,329 | $1.2M | 0.90% | EC |
| 45 | Mirum Pharmaceuticals Inc. | MIRM | Mar 2026 | 13,080 | $1.2M | 0.89% | EC |
| 46 | Protagonist Therapeutics Inc | PTGX | Mar 2026 | 11,198 | $1.2M | 0.87% | EC |
| 47 | Amicus Therapeutics Inc. | FOLD | Mar 2026 | 76,280 | $1.1M | 0.82% | EC |
| 48 | Rhythm Pharmaceuticals Inc | RYTM | Mar 2026 | 12,158 | $1.1M | 0.78% | EC |
| 49 | APOGEE THERAPEUTICS INC | APGE | Mar 2026 | 12,066 | $1.0M | 0.75% | EC |
| 50 | Kymera Therapeutics Inc | KYMR | Mar 2026 | 11,658 | $971K | 0.72% | EC |
| 51 | Twist Bioscience Corporation | TWST | Mar 2026 | 20,054 | $953K | 0.71% | EC |
| 52 | Viking Therapeutics Inc. | VKTX | Mar 2026 | 29,278 | $953K | 0.71% | EC |
| 53 | SUMMIT THERAPEUTICS INC | SMMT | Mar 2026 | 49,213 | $933K | 0.69% | EC |
| 54 | Nuvalent Inc | NUVL | Mar 2026 | 9,053 | $927K | 0.69% | EC |
| 55 | Acadia Pharmaceuticals Inc | ACAD | Mar 2026 | 40,673 | $905K | 0.67% | EC |
| 56 | Travere Therapeutics Inc | TVTX | Mar 2026 | 30,251 | $899K | 0.67% | EC |
| 57 | Sarepta Therapeutics Inc | SRPT | Mar 2026 | 40,226 | $875K | 0.65% | EC |
| 58 | Celcuity Inc. | CELC | Mar 2026 | 7,658 | $874K | 0.65% | EC |
| 59 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | Mar 2026 | 36,923 | $870K | 0.64% | EC |
| 60 | Veracyte Inc | VCYT | Mar 2026 | 26,685 | $860K | 0.64% | EC |
| 61 | LIQUIDIA CORP | LQDA | Mar 2026 | 22,146 | $836K | 0.62% | EC |
| 62 | BEAM THERAPEUTICS INC | BEAM | Mar 2026 | 31,896 | $760K | 0.56% | EC |
| 63 | Ultragenyx Pharmaceuticals Inc | RARE | Mar 2026 | 34,041 | $713K | 0.53% | EC |
| 64 | Praxis Precision Medicines Inc | PRAX | Mar 2026 | 2,092 | $674K | 0.50% | EC |
| 65 | GRAIL Inc | GRAL | Mar 2026 | 12,830 | $663K | 0.49% | EC |
| 66 | Soleno Therapeutics Inc | SLNO | Mar 2026 | 19,659 | $658K | 0.49% | EC |
| 67 | Recursion Pharmaceuticals Inc | RXRX | Mar 2026 | 208,931 | $641K | 0.47% | EC |
| 68 | Krystal Biotech Inc | KRYS | Mar 2026 | 2,474 | $639K | 0.47% | EC |
| 69 | LEGEND BIOTECH CORP | LEGN | Mar 2026 | 35,054 | $634K | 0.47% | EC |
| 70 | Intellia Therapeutics Inc | NTLA | Mar 2026 | 49,463 | $634K | 0.47% | EC |
| 71 | Adma Biologics Inc | ADMA | Mar 2026 | 65,635 | $591K | 0.44% | EC |
| 72 | J.P. MORGAN SECURITIES LLC | 000000000 | Mar 2026 | 311,357 | $311K | 0.23% | RA |
| 73 | MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED | 000000000 | Mar 2026 | 282,954 | $283K | 0.21% | RA |
| 74 | Akero Therapeutics Inc | AKRO | Mar 2026 | 17,387 | $2 | 0.00% | EC |
| 75 | SANOFI SA - CVR | 000000000 | Mar 2026 | 8,866 | $1 | 0.00% | EC |